A service of StreetInsider.com

Most Popular

AAPL 140.02
C 26.20
GOOG 408.49
BAC 27.40
RIMM 69.71

Recently Added

ARDM 0.24
SLAT 0.67
LNT 25.80
NDN 26.28
HTD 10.23

Gaining Speed

XYNH 0.01
ACCP 2.20
SAPE 6.13
HTD 10.23
SNRY 0.57
6.04 -0.15 (-2.47%) ARQL

Click Here to Receive Instant E-mail and RSS Alerts

Stock Details

Last Trade:6.04 Change:-0.15 (-2.47%) Prev Close:6.19 Open: 6.08 Days Range:5.81 – 6.14 52 Week Range: 1.75 - 6.38 Volume:278050 P/E: N/A
EPS:-1.08

Member Comments

No member comments available for ARQL


Not logged in - Log in or Sign up to leave comments

View AllRecent Alerts 07/04/09

Recent Alert on 06/01/09 at 8:16am
ASCO Presentations Highlight Findings from Clinical Trials with ArQule's (ARQL) c-MET Inhibitor, ARQ 197

Investigators presented data at the 2009 Annual Meeting of the American Society of Clinical Oncology (ASCO) from four clinical trials with ARQ 197, an inhibitor of the c-MET receptor tyrosine kinase under development by ArQule, Inc. (Nasdaq: ARQL)... Read More

View AllRecent Press Releases

No Recent Press Releases Available

View AllRecent SEC Filings

No Recent SEC Filings Available

View AllRecent Blog Posts

Blog Posts on 05/27/09 at 8:50am
Top Biotech Picks for ASCO 2009 (Part II)
Blog Posts on 05/27/09 at 8:49am
Top Biotech Picks for ASCO 2009 (Part I)
Blog Posts on 05/11/09 at 10:21am
Micromet: More Reasons for Optimism
Blog Posts on 03/05/09 at 3:45pm
ArQule, Inc. Q4 2008 Earnings Call Transcript
Blog Posts on 08/11/08 at 3:28pm
ArQule, Inc., Q2 2008 Earnings Call Transcript